Kenyan healthtech Tibu Health has secured a financing facility from the French development institution Proparco, channelled through the Bridge Fund by Digital Africa, to expand its network of embedded primary-care clinics. Founded in 2020 by Jason Carmichael, Tibu runs a hub-and-spoke model: small “Minute Clinics,” launched in 2024, placed inside pharmacies, through a partnership with the Goodlife chain, and supermarkets, linked to a central hub offering diagnostics, imaging, paediatrics, gynaecology, lab testing and telemedicine.
Read the instrument, and the blank
Two disclosed facts shape how to read this round, and both get lost in the language of transformation. First, the instrument: this is a bridge facility from a development finance institution, not a venture equity round, which signals capital to extend runway and prove a model rather than a market bet on rapid scale. Second, the amount was not disclosed. TechCocoon Intelligence treats an undisclosed round size, especially a DFI bridge, as information in itself: it usually means the figure is modest relative to the ambition described, or that the company would rather lead with the endorsement than the number. Neither is damning. Both are reasons to anchor on the model’s mechanics rather than the announcement’s adjectives.
Why the model is genuinely sound
The substance here is strong, and it is structural rather than rhetorical. Tibu’s core insight, that care should go to where people already are, is correct, and the execution is asset-light in the right way: rather than building and owning expensive standalone facilities, it embeds clinics inside high-traffic retail space it does not have to construct, sharing footfall with pharmacies and supermarkets. That lowers the capital cost per location and meets patients in places they visit without the friction of a hospital. As Proparco’s deputy chief executive framed it, the model links community-level clinics to a centralised hub for diagnostics and specialist care, which is the part that turns a pharmacy counter into something closer to coordinated primary care.
The questions that decide it
The “bridging healthcare gaps” framing is true as far as it goes, but it is not the test. The test is unit economics: utilisation per clinic, the cost to deliver each consultation, and whether a Minute Clinic covers its own running costs at realistic patient volumes. Embedded care lives or dies on footfall converting to paid visits, on the central hub being used enough to justify its fixed cost, and on margins thin enough to stay affordable yet positive. None of that is visible in this announcement, and all of it determines whether the network is replicable or subsidy-dependent.
The honest tension is the one Tibu’s own backers gesture at: private models like this can be genuine pressure-relief for an overstretched public system, absorbing routine primary care so referral hospitals can focus on complex cases. Or they can prove workable only in dense, higher-income urban pockets and stall when pushed into the rural and peri-urban areas the funding is meant to reach. The model has proven it can exist; scaling it beyond the easy catchments, profitably, is the unresolved question. Watch whether the next disclosure includes clinic-level economics, or another endorsement without a number.
